Comparative Efficacy of Super Bioavailable Itraconazole Capsules 50 mg vs 65 mg Twice Daily in the Management of Glabrous Tinea-Reference-Cited by-同舟云学术

Comparative Efficacy of Super Bioavailable Itraconazole Capsules 50 mg vs 65 mg Twice Daily in the Management of Glabrous Tinea

Published:2023-04 Issue: Volume:Volume 16 Page:2409-2416
ISSN:1178-6973
Container-title:Infection and Drug Resistance
language:en
Short-container-title:IDR

Author:

Shah Bela,Mistry Deval,Jairam Dharmender^ORCID,Kansara Kajal,Pandya Rutvi^ORCID,Vasani Presha,Dhoot Dhiraj^ORCID,Mahadkar Namrata,Bhushan Sumit,Barkate Hanmant

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology

Reference26 articles.

1. Indian association of dermatologists, venereologists and leprologists (IADVL) task force against recalcitrant tinea (ITART) consensus on the management of glabrous tinea (INTACT)

2. The current indian epidemic of dermatophytosis: A study on causative agents and sensitivity patterns

3. Effects of Food and Omeprazole on a Novel Formulation of Super Bioavailability Itraconazole in Healthy Subjects

4. Population Pharmacokinetic Modeling of Itraconazole and Hydroxyitraconazole for Oral SUBA-Itraconazole and Sporanox Capsule Formulations in Healthy Subjects in Fed and Fasted States

5. European Medicines Agency. List of nationally authorised medicinal products. Available from: https://www.ema.europa.eu/en/documents/psusa/itraconazole-list-nationally-authorised-medicinal-products-psusa/00001798/201703_en.pdf. Accessed November 17, 2022.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SUBA-itraconazole in the treatment of systemic fungal infections;Future Microbiology;2024-07-16